CARE FAKEEH

Dr. Soliman Abdul Kader Fakeeh Hospital Co.

4017StocksTadawulHealthcare

Financials

1-5

	CurrentMar 10, 2026	2025Dec 31, 2025	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022
Market & Price
Market Capitalization	7.90B	7.84B	15.41B	—	—
Market Cap Growth	-25.9%	-49.1%	—	—	—
Enterprise Value	9.05B	8.92B	16.09B	—	—
Last Close Price	34.36	34.10	66.51	—	—
Valuation Multiples
Forward PE (Next 12M Est.)	23.85	22.08	42.58	—	—
PE Ratio	30.59	27.03	53.59	—	—
PEG Ratio	1.97	1.49	2.08	—	—
PS Ratio	2.54	2.54	5.52	—	—
PB Ratio	2.21	2.19	4.64	—	—
P/TBV Ratio	3.01	2.99	6.42	—	—
P/OCF Ratio	21.20	17.28	35.34	—	—
EV/Sales Ratio	2.91	2.89	5.76	—	—
EV/EBITDA Ratio	20.91	21.05	34.93	—	—
EV/EBIT Ratio	33.86	28.95	44.80	—	—
Leverage & Capital
Debt / Equity Ratio	0.33	0.33	0.33	1.80	1.04
Debt / EBITDA Ratio	2.72	2.42	2.08	4.72	4.58
Debt / FCF Ratio	—	—	—	70.07	—
Net Debt / Equity Ratio	0.21	0.21	0.16	1.63	0.90
Net Debt / EBITDA Ratio	1.91	1.74	1.18	4.78	4.28
Net Debt / FCF Ratio	-8.31	-97.08	-6.67	63.44	-13.98
Efficiency & Liquidity
Asset Turnover	—	0.55	0.58	0.50	0.47
Inventory Turnover	—	12.73	12.24	11.61	11.26
Quick Ratio	—	1.33	1.69	1.04	0.94
Current Ratio	—	1.63	1.97	1.30	1.19
Returns & Yields
Return on Equity (ROE)	—	+7.2%	+11.5%	+13.6%	+17.0%
Return on Assets (ROA)	—	+3.5%	+4.7%	+4.5%	+5.6%
Return on Invested Capital (ROIC)	+5.4%	+6.7%	+9.2%	+8.2%	+10.6%
Return on Capital Employed (ROCE)	—	+6.5%	+8.2%	+10.5%	+9.8%
Earnings Yield	+3.2%	+3.7%	+1.9%	—	—
FCF Yield	-1.1%	-0.1%	-0.5%	—	—
Dividend Yield	+0.8%	—	+0.5%	—	—
Payout Ratio	+26.9%	+23.8%	—	+411.3%	+10.7%
Buyback Yield / Dilution	-1.6%	-5.9%	-8.6%	—	-100.0%
Total Shareholder Return	-0.7%	-5.9%	-8.1%	—	-100.0%

1-5

	CurrentMar 10, 2026	2025Dec 31, 2025	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022
Market & Price
Market Capitalization	7.90B	7.84B	15.41B	—	—
Market Cap Growth	-25.9%	-49.1%	—	—	—
Enterprise Value	9.05B	8.92B	16.09B	—	—
Last Close Price	34.36	34.10	66.51	—	—
Valuation Multiples
Forward PE (Next 12M Est.)	23.85	22.08	42.58	—	—
PE Ratio	30.59	27.03	53.59	—	—
PEG Ratio	1.97	1.49	2.08	—	—
PS Ratio	2.54	2.54	5.52	—	—
PB Ratio	2.21	2.19	4.64	—	—
P/TBV Ratio	3.01	2.99	6.42	—	—
P/OCF Ratio	21.20	17.28	35.34	—	—
EV/Sales Ratio	2.91	2.89	5.76	—	—
EV/EBITDA Ratio	20.91	21.05	34.93	—	—
EV/EBIT Ratio	33.86	28.95	44.80	—	—
Leverage & Capital
Debt / Equity Ratio	0.33	0.33	0.33	1.80	1.04
Debt / EBITDA Ratio	2.72	2.42	2.08	4.72	4.58
Debt / FCF Ratio	—	—	—	70.07	—
Net Debt / Equity Ratio	0.21	0.21	0.16	1.63	0.90
Net Debt / EBITDA Ratio	1.91	1.74	1.18	4.78	4.28
Net Debt / FCF Ratio	-8.31	-97.08	-6.67	63.44	-13.98
Efficiency & Liquidity
Asset Turnover	—	0.55	0.58	0.50	0.47
Inventory Turnover	—	12.73	12.24	11.61	11.26
Quick Ratio	—	1.33	1.69	1.04	0.94
Current Ratio	—	1.63	1.97	1.30	1.19
Returns & Yields
Return on Equity (ROE)	—	+7.2%	+11.5%	+13.6%	+17.0%
Return on Assets (ROA)	—	+3.5%	+4.7%	+4.5%	+5.6%
Return on Invested Capital (ROIC)	+5.4%	+6.7%	+9.2%	+8.2%	+10.6%
Return on Capital Employed (ROCE)	—	+6.5%	+8.2%	+10.5%	+9.8%
Earnings Yield	+3.2%	+3.7%	+1.9%	—	—
FCF Yield	-1.1%	-0.1%	-0.5%	—	—
Dividend Yield	+0.8%	—	+0.5%	—	—
Payout Ratio	+26.9%	+23.8%	—	+411.3%	+10.7%
Buyback Yield / Dilution	-1.6%	-5.9%	-8.6%	—	-100.0%
Total Shareholder Return	-0.7%	-5.9%	-8.1%	—	-100.0%